Urothelial Carcinoma of the Bladder
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Update: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer [Phase 3]
Phase 3 clinical trial investigating pembrolizumab (MK-3475) after surgery for localized muscle-invasive bladder cancer and locally advanced…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 study is testing pembrolizumab added to intravesical gemcitabine for BCG-unresponsive non-muscle invasive bladder cancer, with the…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the addition of tazemetostat to pembrolizumab in locally advanced or metastatic urothelial carcinom…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Phase Ib of L-NMMA and Pembrolizumab [Phase 1]
This completed Phase 1 trial evaluated the combination of L-NMMA with pembrolizumab across multiple cancers, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC [Phase 2]
Phase 2 trial results of IO102-IO103 in combination with pembrolizumab as first-line therapy for metastatic non-small cell lung cancer, head…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant [Phase 1]
Phase 1 neoadjuvant trial targeting androgen signaling in AR-positive urothelial carcinoma of the bladder has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy [Phase 3]
Phase 3 trial update evaluating the optimal duration of immune checkpoint therapy for locally advanced and metastatic urothelial carcinoma; …
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) [Phase 1]
A Phase 1 dose-escalation study of UGN-301 in patients with recurrent non-muscle invasive bladder cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection [Phase 2, Phase 3]
A completed Phase 2/3 trial from Ain Shams University investigated whether the osmolarity of postoperative irrigation fluids influences the …
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab [Phase 2]
A Phase 2 basket trial evaluating the combination of niraparib and dostarlimab across multiple cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial update describes neoadjuvant sasanlimab with radiation as an in situ vaccine for cisplatin-ineligible muscle invasi…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer [NA]
A Phase II trial evaluating an organ-conserving radiochemotherapy approach for muscle-invasive bladder cancer has been terminated, with resu…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder [Phase 2]
Phase 2 trial of docetaxel in combination with lapatinib for metastatic transitional cell carcinoma of the bladder was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab with gemcitabine and concurrent hypofractionated radiation therapy for muscle-invasiv…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Intervention of Bladder Cancer by CAR-T [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a CAR-T cell therapy for bladder cancer (urothelial carcinoma of the bladder) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma [Phase 2]
A Phase 2 clinical trial evaluated primary excision with preoperative neoadjuvant and adjuvant therapy for oligometastatic urothelial carcin…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder
A completed clinical trial evaluating treatment preferences in Japanese participants with muscle-invasive urothelial carcinoma of the bladde…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder [Phase 1, Phase 2]
Update on a Phase 1/2 trial of durvalumab with radiation followed by adjuvant durvalumab in urothelial carcinoma of the bladder; the study h…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Can VI-RADS/ADC Accurately Stage Bladder Cancer?? [NA]
This clinical trial update discusses evaluating VI-RADS/ADC imaging to stage bladder cancer, with the study currently active but not recruit…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of NGM831 as a monotherapy and in combination with pembrolizumab (with or without NGM438) in advanced or metastatic solid tu…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
Phase 3 trial update evaluating feasibility of at-home instillation of UGN-102 for low-grade non-muscle invasive bladder cancer. Results wer…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in recurrent BCG-unresponsive non-muscle invasive bladder cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma [Phase 2]
Phase 2 trial update on neoadjuvant pembrolizumab for muscle-invasive urothelial bladder carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Study of Tislelizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 study of tislelizumab in locally advanced or metastatic urothelial bladder cancer has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume [Phase 4]
Phase 4 clinical trial update evaluating the impact of intravesical BCG and gemcitabine on semen quality and testicular volume in urothelial…